Concord Medical Services (NYSE:CCM) Earns Sell Rating from Analysts at StockNews.com

Analysts at StockNews.com started coverage on shares of Concord Medical Services (NYSE:CCM) in a research report issued to clients and investors on Friday. The brokerage set a “sell” rating on the stock.

Concord Medical Services Trading Down 6.1 %

Shares of NYSE CCM opened at $5.53 on Friday. Concord Medical Services has a 52 week low of $3.82 and a 52 week high of $26.70. The business’s 50 day moving average price is $6.68 and its 200 day moving average price is $7.13. The company has a current ratio of 0.47, a quick ratio of 0.46 and a debt-to-equity ratio of 1.15.

About Concord Medical Services

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.